Attempted Tumor Therapy Complicated by a Viroid Associate of the Tumor
Author Information
Author(s): K. Lapis, A. J. S. Davies
Primary Institution: Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, London
Hypothesis
Can syngeneic bone marrow therapy improve survival in mice with NK/Ly ascites tumors treated with Degranol or irradiation?
Conclusion
The study found that high doses of anti-tumor agents were insufficient to eradicate the tumor, and treated animals died before controls due to a virus associated with the tumor that impeded recovery.
Supporting Evidence
- The study showed that syngeneic bone marrow therapy was effective after 850 r X-rays.
- High doses of Degranol were moderately effective but had toxic effects.
- All treated animals showed signs of the tumor at death, indicating treatment failure.
Takeaway
Researchers tried to treat mice with a type of cancer using special drugs and bone marrow, but the treatment didn't work because a virus made the mice too sick.
Methodology
CBA female mice were treated with either Degranol or irradiation followed by syngeneic bone marrow therapy, and their survival was monitored.
Limitations
The study did not achieve tumor eradication and the presence of a virus complicated the treatment outcomes.
Participant Demographics
CBA female mice, weighing 20-25 g.
Want to read the original?
Access the complete publication on the publisher's website